Browsing Tag
Paige
3 posts
Tempus AI company profile: How diagnostics, health data and AI are building a precision medicine platform
Tempus AI, Inc. has built a precision medicine business around genomic diagnostics, multimodal health data, artificial intelligence and pharmaceutical research services. Ambry Genetics, Deep 6 AI, Paige and OneOme have widened that platform, while the proposed Personalis acquisition could bring molecular residual disease technology, laboratory economics and longitudinal cancer monitoring more tightly inside the company.
August 30, 2026
Tempus (Nasdaq: TEM) gains real-world NHS evidence for Paige Prostate AI, but scale-up still depends on economics
Prospective NHS deployment strengthens the clinical case for Tempus AI’s digital pathology portfolio, although cost effectiveness, infrastructure readiness and commercial conversion remain unproven.
July 16, 2026
The business of AI in oncology: Who’s building the platforms hospitals trust?
Tempus, Guardant, Freenome, and Paige are building the AI oncology platforms hospitals now rely on. Discover the financials and future shaping cancer diagnostics.
June 5, 2025